Judges from around the world deemed Retia Medical to have had the most novel, market potential and overall impact on healthcare in today's Hemodynamic Market.

WHITE PLAINS, NEW YORK, UNITED STATES, October 24, 2023 /EINPresswire.com/ -- In a thrilling display of healthcare innovation and entrepreneurial prowess, Retia Medical has clinched the prestigious title of Global Pitch Championship Winner at the Med-tech World conference being held in Malta. Prevailing over nine other outstanding start-ups, an international panel of judges unanimously recognized Retia Medical as the standout contender, acknowledging the company's groundbreaking contributions to the healthcare industry.

The Med-Tech World competition, which attracted start-ups from diverse corners of the globe, witnessed fierce rivalry, but Retia Medical's innovation, feasibility, market potential, and overall impact on healthcare set them apart as the undisputed champions. Judges from around the world commended Retia Medical for their unparalleled novelty, practicality, and transformative effect on the healthcare landscape. Their victory stands as a testament to the company's dedication to driving meaningful change and improving patient outcomes.

"We are incredibly honored and humbled by this recognition," said Marc Zemel, CEO at Retia Medical. "This achievement validates our team's hard work, determination, and the overall benefits our Argos monitor brings to so many critically ill patients. We are more motivated than ever to continue our mission of making a lasting impact on the healthcare industry, improving patient outcomes, and pushing the boundaries of what's possible with our product."

Circulatory Shock in critically ill patients is a life-threatening condition characterized by a severe impairment in tissue perfusion, leading to inadequate oxygen and nutrient delivery to vital organs. Often misdiagnosed as hypotension, shock is a primary cause of complications such as acute kidney injury, cardiac injury, sepsis and more in the OR and in the ICU. When this happens, clinicians have 1-2 minutes to prevent damage to vital organs. Prompt recognition and appropriate resuscitation are crucial to improve patient outcomes. The management of shock in critically ill patients requires a timely intervention with hemodynamic-guided therapy to ensure sufficient oxygen delivery and minimize organ damage in these high-risk patients.

Retia Medical's Argos System stands out in the market for its outstanding clinical performance having been proven in the toughest patient populations: cardiogenic shock, cardiac surgery, liver transplant, off pump cardiac surgery, neurosurgery, major abdominal surgery, heart failure and post-surgery in the ICU.

Powered by its MBA algorithm, the Argos has the ability to detect early onsets of shock to ensure clinicians can guide the appropriate care management to those critically ill patients and avoid costly complications. Its minimally invasive nature and ability to integrate seamlessly with existing patient monitoring systems make it a valuable addition to healthcare facilities seeking to enhance their cardiac monitoring capabilities. With its simple one cable connection, the Argos system allows clinicians to monitor more patients without worrying about added costs associated with costly disposables.

Humberto Contreras
Retia Medical
+1 203-814-7987
hcontreras@retiamedical.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.